care to change your tune as to expected outcomes for PEARL 2/3 non-rib containing arms now? if memory serves (I don't have search access) I questioned your estimates
adding abt-333 should only add to these efficacy numbers even though some 1b patients carry a baseline resistance mutation to the drug